Chronic pancreatitis
Conditions
Interventions
600mg of Pancrelipase (granules or capsels) to be taken three times a day (1800mg /day) after meals for 4 weeks.
Sponsors
Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Chronic pancreatitis patients 1)Patient who has intention according to plan 2)Patient who is sign in document 3)Patient suffering from dyspepsia 4)Patient whose BT-PABA test results are 70% or less (Suspected CP or early-stage CP)
Exclusion criteria
Exclusion criteria: 1)Alegyin procion protein or digestive enzym 2)Case with possibility of pregnancy,during nursing 3)Participates in other examinations. 4)Sever infection 5)In addition, the case judged to be inappropriate for the examination to carry out this study safely
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of albumin | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)Change of amylase and lipase 2)Improvement of nutrition 3)Improvement of VAS score 4)Improvement of dyspepsia 5)Improvement of stool consistency and count | — |
Countries
Japan
Contacts
Public ContactTomoji Yamamoto
Department of Internal Medicine Second Teaching Hospital Fujita Health University School of Medicine Gastroenterology
Outcome results
None listed